Pauline Conde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pauline Conde has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Yatharth Ranjan
Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
22 shared publications - Amos Folarin
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
19 shared publications - Richard Dobson
King's College London, London, United Kingdom
19 shared publications - Zulqarnain Rashid
Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
17 shared publications - Heet Sankesara
Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
12 shared publications - Callum Stewart
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London SE5 8AF, UK
10 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Linking consumer health measures from smartphones and wearables with UK national data assets: Protocol for Physical Activity Patterns after Knee Arthroplasty (PAPrKA), a retrospective cohort study (Preprint)
BACKGROUND Knee replacement surgery is performed for people with end-stage knee osteoarthritis to reduce pain and improve activity participation. However, patients have limited evidence on how quickly they can expect to return to normal physical activity after surgery, and how much better their activity will get. Smartphones and consumer-grade wearables capture step count data on individuals' devices. Linked with detailed surgical information, these data could provide a unique opportunity to address this question. However, linking consumer data with national health data, which are currently held separately, is uncharted territory and comes with operational challenges. OBJECTIVE This study has two objectives. The first is to describe physical activity patterns after knee replacement surgery in people with knee osteoarthritis, and the second is to understand how researchers can successfully conduct retrospective cohort studies that link consumer activity data collected through smartphones and consumer wearables with national health datasets through this worked example. METHODS We aim to recruit up to 1,000 people aged 18 or older who had knee osteoarthritis and a knee replacement in England, Wales, Northern Ireland, Isle of Man, or Guernsey between 1st January 2017 to 31st December 2023. Participants are eligible if they used Fitbit, Apple (iPhone or Apple Watch), or Oura Ring devices to track physical activity in the six months before and one year after surgery. Study participants will have to complete three tasks: answer questions about their surgery, provide identifiers for linkage, and provide access to physical activity information from their devices. Physical activity data will be linked to an extract of data from their surgical health record in the National Joint Registry. The primary outcome for the first objective will be post-operative relative daily step count, calculated by dividing post-operative daily step count by a pre-operative baseline level. We will assess the extent to which step count increases post-surgery using linear mixed-effects models and explore trajectory groupings using latent class mixed models. For the second objective, we will summarise sources of referral to the study and their corresponding conversion rate, cumulative recruitment numbers, website engagement, representativeness, and completeness of physical activity data. RESULTS The study started recruitment in November 2025, with 132 participants onboarded as of 24 June 2026. We will complete recruitment on 31 July 2026 and aim to publish results by December 2026. CONCLUSIONS Understanding how physical activity changes after knee replacement surgery could help patients and clinicians make more informed decisions based on anticipated future physical activity levels and recovery patterns. Through this worked example, we will generate learning about how to conduct retrospective cohort studies linking consumer health measures to national healthcare datasets, particularly regarding recruitment and study onboarding. CLINICALTRIAL ISRCTN41610298
- 29 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessLinking consumer health measures from smartphones and wearables with UK national data assets: Protocol for Physical Activity Patterns after Knee Arthroplasty (PAPrKA), a retrospective cohort study (Preprint)
BACKGROUND Knee replacement surgery is performed for people with end-stage knee osteoarthritis to reduce pain and improve activity participation. However, patients have limited evidence on how quickly they can expect to return to normal physical activity after surgery, and how much better their activity will get. Smartphones and consumer-grade wearables capture step count data on individuals' devices. Linked with detailed surgical information, these data could provide a unique opportunity to address this question. However, linking consumer data with national health data, which are currently held separately, is uncharted territory and comes with operational challenges. OBJECTIVE This study has two objectives. The first is to describe physical activity patterns after knee replacement surgery in people with knee osteoarthritis, and the second is to understand how researchers can successfully conduct retrospective cohort studies that link consumer activity data collected through smartphones and consumer wearables with national health datasets through this worked example. METHODS We aim to recruit up to 1,000 people aged 18 or older who had knee osteoarthritis and a knee replacement in England, Wales, Northern Ireland, Isle of Man, or Guernsey between 1st January 2017 to 31st December 2023. Participants are eligible if they used Fitbit, Apple (iPhone or Apple Watch), or Oura Ring devices to track physical activity in the six months before and one year after surgery. Study participants will have to complete three tasks: answer questions about their surgery, provide identifiers for linkage, and provide access to physical activity information from their devices. Physical activity data will be linked to an extract of data from their surgical health record in the National Joint Registry. The primary outcome for the first objective will be post-operative relative daily step count, calculated by dividing post-operative daily step count by a pre-operative baseline level. We will assess the extent to which step count increases post-surgery using linear mixed-effects models and explore trajectory groupings using latent class mixed models. For the second objective, we will summarise sources of referral to the study and their corresponding conversion rate, cumulative recruitment numbers, website engagement, representativeness, and completeness of physical activity data. RESULTS The study started recruitment in November 2025, with 132 participants onboarded as of 24 June 2026. We will complete recruitment on 31 July 2026 and aim to publish results by December 2026. CONCLUSIONS Understanding how physical activity changes after knee replacement surgery could help patients and clinicians make more informed decisions based on anticipated future physical activity levels and recovery patterns. Through this worked example, we will generate learning about how to conduct retrospective cohort studies linking consumer health measures to national healthcare datasets, particularly regarding recruitment and study onboarding. CLINICALTRIAL ISRCTN41610298
- 2 January 2026
- Published by Springer Nature
- p. 58-77
Real-Time Mobile Health Analytics and Interventions Pipeline to Detect Acute Events in COPD
- 2 January 2026
- Published by Springer Nature
- p. 58-77
Real-Time Mobile Health Analytics and Interventions Pipeline to Detect Acute Events in COPD
- Open Access
- 12 October 2025
- Published by Association for Computing Machinery (ACM)
- p. 206-210
Participant Engagement and Data Compliance in Remote Digital Studies for ADHD, Autism, and Eating Disorders
- 12 October 2025
- Published by Association for Computing Machinery (ACM)
- p. 206-210
Open AccessParticipant Engagement and Data Compliance in Remote Digital Studies for ADHD, Autism, and Eating Disorders
- Open Access
- 3 October 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e71145
A Dual In-Person and Remote Assessment Approach to Developing Digital End Points Relevant to Autism and Co-Occurring Conditions: Protocol for a Multisite Observational Study
Background: Research priorities for autistic people include developing effective interventions for the numerous challenges affecting their daily living, for example, mental health problems, sleep difficulties, and social well-being. However, clinical research progress is limited by a lack of validated objective measures that represent target outcomes for improvement. Digital technologies, including wearable devices and smartphone apps, provide opportunities to develop novel measures that may reflect everyday experience and complement key clinical assessments. However, little is known about the acceptability and feasibility of implementing digital data collection in this population. Objective: The primary objective of this study is to evaluate the usability, acceptability, adherence, and feasibility of a dual in-person and remote (ie, at-home) protocol. Secondarily, we aim to explore the properties of certain resulting data with a view to developing novel digital end points for key target outcomes, including social communication, sleep, and mental health. Methods: Eligible autistic and nonautistic in the AIMS Longitudinal European Autism Project were invited to participate in a digitally augmented in-person Autism Diagnostic Observation Schedule-2 (ADOS-2) and a 28-day remote measurement (RM) protocol involving wearing a Fitbit device, downloading a passive smartphone data collection app, and using 2 active reporting apps. Results: The first AIMS Longitudinal European Autism Project study participants were enrolled in September 2021 (in-person component) and March 2022 (RM component). To date, 190 participants have taken part in the digitally augmented ADOS-2 component, and 86 participants have been enrolled for the RM protocol. Recruitment is now complete with some RM data collection ongoing until August 2025. Data analysis has commenced, including qualitative framework analysis of feedback interview data coproduced with autism community members, exploration of acceptability and feasibility metrics, pipeline development for ADOS-2 speech analysis, and RM sleep measures. Conclusions: This study lays important groundwork in understanding the acceptability and feasibility of in-person and remotely implemented digital measurement procedures to capture meaningful outcomes in domains important to improving everyday life for autistic people. International Registered Report Identifier (IRRID): DERR1-10.2196/71145
- 3 October 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e71145
Open AccessA Dual In-Person and Remote Assessment Approach to Developing Digital End Points Relevant to Autism and Co-Occurring Conditions: Protocol for a Multisite Observational Study
Background: Research priorities for autistic people include developing effective interventions for the numerous challenges affecting their daily living, for example, mental health problems, sleep difficulties, and social well-being. However, clinical research progress is limited by a lack of validated objective measures that represent target outcomes for improvement. Digital technologies, including wearable devices and smartphone apps, provide opportunities to develop novel measures that may reflect everyday experience and complement key clinical assessments. However, little is known about the acceptability and feasibility of implementing digital data collection in this population. Objective: The primary objective of this study is to evaluate the usability, acceptability, adherence, and feasibility of a dual in-person and remote (ie, at-home) protocol. Secondarily, we aim to explore the properties of certain resulting data with a view to developing novel digital end points for key target outcomes, including social communication, sleep, and mental health. Methods: Eligible autistic and nonautistic in the AIMS Longitudinal European Autism Project were invited to participate in a digitally augmented in-person Autism Diagnostic Observation Schedule-2 (ADOS-2) and a 28-day remote measurement (RM) protocol involving wearing a Fitbit device, downloading a passive smartphone data collection app, and using 2 active reporting apps. Results: The first AIMS Longitudinal European Autism Project study participants were enrolled in September 2021 (in-person component) and March 2022 (RM component). To date, 190 participants have taken part in the digitally augmented ADOS-2 component, and 86 participants have been enrolled for the RM protocol. Recruitment is now complete with some RM data collection ongoing until August 2025. Data analysis has commenced, including qualitative framework analysis of feedback interview data coproduced with autism community members, exploration of acceptability and feasibility metrics, pipeline development for ADOS-2 speech analysis, and RM sleep measures. Conclusions: This study lays important groundwork in understanding the acceptability and feasibility of in-person and remotely implemented digital measurement procedures to capture meaningful outcomes in domains important to improving everyday life for autistic people. International Registered Report Identifier (IRRID): DERR1-10.2196/71145
- Open Access
- 29 January 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9 (1) , e54531
Identifying Digital Markers of Attention-Deficit/Hyperactivity Disorder (ADHD) in a Remote Monitoring Setting: Prospective Observational Study
Background: The symptoms and associated characteristics of attention-deficit/hyperactivity disorder (ADHD) are typically assessed in person at a clinic or in a research lab. Mobile health offers a new approach to obtaining additional passively and continuously measured real-world behavioral data. Using our new ADHD remote technology (ART) system, based on the Remote Assessment of Disease and Relapses (RADAR)–base platform, we explore novel digital markers for their potential to identify behavioral patterns associated with ADHD. The RADAR-base Passive App and wearable device collect sensor data in the background, while the Active App involves participants completing clinical symptom questionnaires. Objective: The main aim of this study was to investigate whether adults and adolescents with ADHD differ from individuals without ADHD on 10 digital signals that we hypothesize capture lapses in attention, restlessness, or impulsive behaviors. Methods: We collected data over 10 weeks from 20 individuals with ADHD and 20 comparison participants without ADHD between the ages of 16 and 39 years. We focus on features derived from (1) Active App (mean and SD of questionnaire notification response latency and of the time interval between questionnaires), (2) Passive App (daily mean and SD of response time to social and communication app notifications, the SD in ambient light during phone use, total phone use time, and total number of new apps added), and (3) a wearable device (Fitbit) (daily steps taken while active on the phone). Linear mixed models and t tests were employed to assess the group differences for repeatedly measured and time-aggregated variables, respectively. Effect sizes ( d ) convey the magnitude of differences. Results: Group differences were significant for 5 of the 10 variables. The participants with ADHD were (1) slower ( P =.047, d =1.05) and more variable ( P =.01, d =0.84) in their speed of responding to the notifications to complete the questionnaires, (2) had a higher SD in the time interval between questionnaires ( P =.04, d =1.13), (3) had higher daily mean response time to social and communication app notifications ( P =.03, d =0.7), and (4) had a greater change in ambient (background) light when they were actively using the smartphone ( P =.008, d =0.86). Moderate to high effect sizes with nonsignificant P values were additionally observed for the mean of time intervals between questionnaires ( P =.06, d =0.82), daily SD in responding to social and communication app notifications ( P =.05, d =0.64), and steps taken while active on the phone ( P =.09, d =0.61). The groups did not differ in the total phone use time ( P =.11, d =0.54) and the number of new apps downloaded ( P =.24, d =0.18). Conclusions: In a novel exploration of digital markers of ADHD, we identified candidate digital signals of restlessness, inconsistent attention, and difficulties completing tasks. Larger future studies are needed to replicate these findings and to assess the potential of such objective digital signals for tracking ADHD severity or predicting outcomes.
- 29 January 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9 (1) , e54531
Open AccessIdentifying Digital Markers of Attention-Deficit/Hyperactivity Disorder (ADHD) in a Remote Monitoring Setting: Prospective Observational Study
Background: The symptoms and associated characteristics of attention-deficit/hyperactivity disorder (ADHD) are typically assessed in person at a clinic or in a research lab. Mobile health offers a new approach to obtaining additional passively and continuously measured real-world behavioral data. Using our new ADHD remote technology (ART) system, based on the Remote Assessment of Disease and Relapses (RADAR)–base platform, we explore novel digital markers for their potential to identify behavioral patterns associated with ADHD. The RADAR-base Passive App and wearable device collect sensor data in the background, while the Active App involves participants completing clinical symptom questionnaires. Objective: The main aim of this study was to investigate whether adults and adolescents with ADHD differ from individuals without ADHD on 10 digital signals that we hypothesize capture lapses in attention, restlessness, or impulsive behaviors. Methods: We collected data over 10 weeks from 20 individuals with ADHD and 20 comparison participants without ADHD between the ages of 16 and 39 years. We focus on features derived from (1) Active App (mean and SD of questionnaire notification response latency and of the time interval between questionnaires), (2) Passive App (daily mean and SD of response time to social and communication app notifications, the SD in ambient light during phone use, total phone use time, and total number of new apps added), and (3) a wearable device (Fitbit) (daily steps taken while active on the phone). Linear mixed models and t tests were employed to assess the group differences for repeatedly measured and time-aggregated variables, respectively. Effect sizes ( d ) convey the magnitude of differences. Results: Group differences were significant for 5 of the 10 variables. The participants with ADHD were (1) slower ( P =.047, d =1.05) and more variable ( P =.01, d =0.84) in their speed of responding to the notifications to complete the questionnaires, (2) had a higher SD in the time interval between questionnaires ( P =.04, d =1.13), (3) had higher daily mean response time to social and communication app notifications ( P =.03, d =0.7), and (4) had a greater change in ambient (background) light when they were actively using the smartphone ( P =.008, d =0.86). Moderate to high effect sizes with nonsignificant P values were additionally observed for the mean of time intervals between questionnaires ( P =.06, d =0.82), daily SD in responding to social and communication app notifications ( P =.05, d =0.64), and steps taken while active on the phone ( P =.09, d =0.61). The groups did not differ in the total phone use time ( P =.11, d =0.54) and the number of new apps downloaded ( P =.24, d =0.18). Conclusions: In a novel exploration of digital markers of ADHD, we identified candidate digital signals of restlessness, inconsistent attention, and difficulties completing tasks. Larger future studies are needed to replicate these findings and to assess the potential of such objective digital signals for tracking ADHD severity or predicting outcomes.
- Open Access
- 21 January 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Dual In-Person and Remote Assessment Approach to Developing Digital End Points Relevant to Autism and Co-Occurring Conditions: Protocol for a Multisite Observational Study (Preprint)
BACKGROUND Research priorities for autistic people include developing effective interventions for the numerous challenges affecting their daily living, for example, mental health problems, sleep difficulties, and social well-being. However, clinical research progress is limited by a lack of validated objective measures that represent target outcomes for improvement. Digital technologies, including wearable devices and smartphone apps, provide opportunities to develop novel measures that may reflect everyday experience and complement key clinical assessments. However, little is known about the acceptability and feasibility of implementing digital data collection in this population. OBJECTIVE The primary objective of this study is to evaluate the usability, acceptability, adherence, and feasibility of a dual in-person and remote (ie, at-home) protocol. Secondarily, we aim to explore the properties of certain resulting data with a view to developing novel digital end points for key target outcomes, including social communication, sleep, and mental health. METHODS Eligible autistic and nonautistic in the AIMS Longitudinal European Autism Project were invited to participate in a digitally augmented in-person Autism Diagnostic Observation Schedule-2 (ADOS-2) and a 28-day remote measurement (RM) protocol involving wearing a Fitbit device, downloading a passive smartphone data collection app, and using 2 active reporting apps. RESULTS The first AIMS Longitudinal European Autism Project study participants were enrolled in September 2021 (in-person component) and March 2022 (RM component). To date, 190 participants have taken part in the digitally augmented ADOS-2 component, and 86 participants have been enrolled for the RM protocol. Recruitment is now complete with some RM data collection ongoing until August 2025. Data analysis has commenced, including qualitative framework analysis of feedback interview data coproduced with autism community members, exploration of acceptability and feasibility metrics, pipeline development for ADOS-2 speech analysis, and RM sleep measures. CONCLUSIONS This study lays important groundwork in understanding the acceptability and feasibility of in-person and remotely implemented digital measurement procedures to capture meaningful outcomes in domains important to improving everyday life for autistic people. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/71145
- 21 January 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Dual In-Person and Remote Assessment Approach to Developing Digital End Points Relevant to Autism and Co-Occurring Conditions: Protocol for a Multisite Observational Study (Preprint)
BACKGROUND Research priorities for autistic people include developing effective interventions for the numerous challenges affecting their daily living, for example, mental health problems, sleep difficulties, and social well-being. However, clinical research progress is limited by a lack of validated objective measures that represent target outcomes for improvement. Digital technologies, including wearable devices and smartphone apps, provide opportunities to develop novel measures that may reflect everyday experience and complement key clinical assessments. However, little is known about the acceptability and feasibility of implementing digital data collection in this population. OBJECTIVE The primary objective of this study is to evaluate the usability, acceptability, adherence, and feasibility of a dual in-person and remote (ie, at-home) protocol. Secondarily, we aim to explore the properties of certain resulting data with a view to developing novel digital end points for key target outcomes, including social communication, sleep, and mental health. METHODS Eligible autistic and nonautistic in the AIMS Longitudinal European Autism Project were invited to participate in a digitally augmented in-person Autism Diagnostic Observation Schedule-2 (ADOS-2) and a 28-day remote measurement (RM) protocol involving wearing a Fitbit device, downloading a passive smartphone data collection app, and using 2 active reporting apps. RESULTS The first AIMS Longitudinal European Autism Project study participants were enrolled in September 2021 (in-person component) and March 2022 (RM component). To date, 190 participants have taken part in the digitally augmented ADOS-2 component, and 86 participants have been enrolled for the RM protocol. Recruitment is now complete with some RM data collection ongoing until August 2025. Data analysis has commenced, including qualitative framework analysis of feedback interview data coproduced with autism community members, exploration of acceptability and feasibility metrics, pipeline development for ADOS-2 speech analysis, and RM sleep measures. CONCLUSIONS This study lays important groundwork in understanding the acceptability and feasibility of in-person and remotely implemented digital measurement procedures to capture meaningful outcomes in domains important to improving everyday life for autistic people. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/71145
- Open Access
- 23 October 2024
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 11 (1) , e51259
Digital Phenotyping of Mental and Physical Conditions: Remote Monitoring of Patients Through RADAR-Base Platform
Background: The use of digital biomarkers through remote patient monitoring offers valuable and timely insights into a patient’s condition, including aspects such as disease progression and treatment response. This serves as a complementary resource to traditional health care settings leveraging mobile technology to improve scale and lower latency, cost, and burden. Objective: Smartphones with embedded and connected sensors have immense potential for improving health care through various apps and mobile health (mHealth) platforms. This capability could enable the development of reliable digital biomarkers from long-term longitudinal data collected remotely from patients. Methods: We built an open-source platform, RADAR-base, to support large-scale data collection in remote monitoring studies. RADAR-base is a modern remote data collection platform built around Confluent’s Apache Kafka to support scalability, extensibility, security, privacy, and quality of data. It provides support for study design and setup and active (eg, patient-reported outcome measures) and passive (eg, phone sensors, wearable devices, and Internet of Things) remote data collection capabilities with feature generation (eg, behavioral, environmental, and physiological markers). The back end enables secure data transmission and scalable solutions for data storage, management, and data access. Results: The platform has been used to successfully collect longitudinal data for various cohorts in a number of disease areas including multiple sclerosis, depression, epilepsy, attention-deficit/hyperactivity disorder, Alzheimer disease, autism, and lung diseases. Digital biomarkers developed through collected data are providing useful insights into different diseases. Conclusions: RADAR-base offers a contemporary, open-source solution driven by the community for remotely monitoring, collecting data, and digitally characterizing both physical and mental health conditions. Clinicians have the ability to enhance their insight through the use of digital biomarkers, enabling improved prevention, personalization, and early intervention in the context of disease management.
- 23 October 2024
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 11 (1) , e51259
Open AccessDigital Phenotyping of Mental and Physical Conditions: Remote Monitoring of Patients Through RADAR-Base Platform
Background: The use of digital biomarkers through remote patient monitoring offers valuable and timely insights into a patient’s condition, including aspects such as disease progression and treatment response. This serves as a complementary resource to traditional health care settings leveraging mobile technology to improve scale and lower latency, cost, and burden. Objective: Smartphones with embedded and connected sensors have immense potential for improving health care through various apps and mobile health (mHealth) platforms. This capability could enable the development of reliable digital biomarkers from long-term longitudinal data collected remotely from patients. Methods: We built an open-source platform, RADAR-base, to support large-scale data collection in remote monitoring studies. RADAR-base is a modern remote data collection platform built around Confluent’s Apache Kafka to support scalability, extensibility, security, privacy, and quality of data. It provides support for study design and setup and active (eg, patient-reported outcome measures) and passive (eg, phone sensors, wearable devices, and Internet of Things) remote data collection capabilities with feature generation (eg, behavioral, environmental, and physiological markers). The back end enables secure data transmission and scalable solutions for data storage, management, and data access. Results: The platform has been used to successfully collect longitudinal data for various cohorts in a number of disease areas including multiple sclerosis, depression, epilepsy, attention-deficit/hyperactivity disorder, Alzheimer disease, autism, and lung diseases. Digital biomarkers developed through collected data are providing useful insights into different diseases. Conclusions: RADAR-base offers a contemporary, open-source solution driven by the community for remotely monitoring, collecting data, and digitally characterizing both physical and mental health conditions. Clinicians have the ability to enhance their insight through the use of digital biomarkers, enabling improved prevention, personalization, and early intervention in the context of disease management.
- Open Access
- 5 October 2024
- Published by Association for Computing Machinery (ACM)
- p. 96-100
Remote Monitoring of Epilepsy Patients with Wearable Device and Smartphone
- 5 October 2024
- Published by Association for Computing Machinery (ACM)
- p. 96-100
Open AccessRemote Monitoring of Epilepsy Patients with Wearable Device and Smartphone
- Open Access
RADAR-IoT: An Open-Source, Interoperable, and Extensible IoT Gateway Framework for Health Research
IoT sensors offer a wide range of sensing capabilities, many of which have potential health applications. Existing solutions for IoT in healthcare have notable limitations, such as closed-source, limited I/O protocols, limited cloud platform support, and missing specific functionality for health use cases. Developing an open-source internet of things (IoT) gateway solution that addresses these limitations and provides reliability, broad applicability, and utility is highly desirable. Combining a wide range of sensor data streams from IoT devices with ambulatory mHealth data would open up the potential to provide a detailed 360-degree view of the relationship between patient physiology, behavior, and environment. We have developed RADAR-IoT as an open-source IoT gateway framework, to harness this potential. It aims to connect multiple IoT devices at the edge, perform limited on-device data processing and analysis, and integrate with cloud-based mobile health platforms, such as RADAR-base, enabling real-time data processing. We also present a proof-of-concept data collection from this framework, using prototype hardware in two locations. The RADAR-IoT framework, combined with the RADAR-base mHealth platform, provides a comprehensive view of a user’s health and environment by integrating static IoT sensors and wearable devices. Despite its current limitations, it offers a promising open-source solution for health research, with potential applications in managing infection control, monitoring chronic pulmonary disorders, and assisting patients with impaired motor control or cognitive ability.
Open AccessRADAR-IoT: An Open-Source, Interoperable, and Extensible IoT Gateway Framework for Health Research
IoT sensors offer a wide range of sensing capabilities, many of which have potential health applications. Existing solutions for IoT in healthcare have notable limitations, such as closed-source, limited I/O protocols, limited cloud platform support, and missing specific functionality for health use cases. Developing an open-source internet of things (IoT) gateway solution that addresses these limitations and provides reliability, broad applicability, and utility is highly desirable. Combining a wide range of sensor data streams from IoT devices with ambulatory mHealth data would open up the potential to provide a detailed 360-degree view of the relationship between patient physiology, behavior, and environment. We have developed RADAR-IoT as an open-source IoT gateway framework, to harness this potential. It aims to connect multiple IoT devices at the edge, perform limited on-device data processing and analysis, and integrate with cloud-based mobile health platforms, such as RADAR-base, enabling real-time data processing. We also present a proof-of-concept data collection from this framework, using prototype hardware in two locations. The RADAR-IoT framework, combined with the RADAR-base mHealth platform, provides a comprehensive view of a user’s health and environment by integrating static IoT sensors and wearable devices. Despite its current limitations, it offers a promising open-source solution for health research, with potential applications in managing infection control, monitoring chronic pulmonary disorders, and assisting patients with impaired motor control or cognitive ability.
- Open Access
- 19 January 2024
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 12 (1) , e44214
Engagement With a Remote Symptom-Tracking Platform Among Participants With Major Depressive Disorder: Randomized Controlled Trial
Background: Multiparametric remote measurement technologies (RMTs), which comprise smartphones and wearable devices, have the potential to revolutionize understanding of the etiology and trajectory of major depressive disorder (MDD). Engagement with RMTs in MDD research is of the utmost importance for the validity of predictive analytical methods and long-term use and can be conceptualized as both objective engagement (data availability) and subjective engagement (system usability and experiential factors). Positioning the design of user interfaces within the theoretical framework of the Behavior Change Wheel can help maximize effectiveness. In-app components containing information from credible sources, visual feedback, and access to support provide an opportunity to promote engagement with RMTs while minimizing team resources. Randomized controlled trials are the gold standard in quantifying the effects of in-app components on engagement with RMTs in patients with MDD. Objective: This study aims to evaluate whether a multiparametric RMT system with theoretically informed notifications, visual progress tracking, and access to research team contact details could promote engagement with remote symptom tracking over and above the system as usual. We hypothesized that participants using the adapted app (intervention group) would have higher engagement in symptom monitoring, as measured by objective and subjective engagement. Methods: A 2-arm, parallel-group randomized controlled trial (participant-blinded) with 1:1 randomization was conducted with 100 participants with MDD over 12 weeks. Participants in both arms used the RADAR-base system, comprising a smartphone app for weekly symptom assessments and a wearable Fitbit device for continuous passive tracking. Participants in the intervention arm (n=50, 50%) also had access to additional in-app components. The primary outcome was objective engagement, measured as the percentage of weekly questionnaires completed during follow-up. The secondary outcomes measured subjective engagement (system engagement, system usability, and emotional self-awareness). Results: The levels of completion of the Patient Health Questionnaire-8 (PHQ-8) were similar between the control (67/97, 69%) and intervention (66/97, 68%) arms (P value for the difference between the arms=.83, 95% CI −9.32 to 11.65). The intervention group participants reported slightly higher user engagement (1.93, 95% CI −1.91 to 5.78), emotional self-awareness (1.13, 95% CI −2.93 to 5.19), and system usability (2.29, 95% CI −5.93 to 10.52) scores than the control group participants at follow-up; however, all CIs were wide and included 0. Process evaluation suggested that participants saw the in-app components as helpful in increasing task completion. Conclusions: The adapted system did not increase objective or subjective engagement in remote symptom tracking in our research cohort. This study provides an important foundation for understanding engagement with RMTs for research and the methodologies by which this work can be replicated in both community and clinical settings. Trial Registration: ClinicalTrials.gov NCT04972474; https://clinicaltrials.gov/ct2/show/NCT04972474 International Registered Report Identifier (IRRID): RR2-10.2196/32653
- 19 January 2024
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 12 (1) , e44214
Open AccessEngagement With a Remote Symptom-Tracking Platform Among Participants With Major Depressive Disorder: Randomized Controlled Trial
Background: Multiparametric remote measurement technologies (RMTs), which comprise smartphones and wearable devices, have the potential to revolutionize understanding of the etiology and trajectory of major depressive disorder (MDD). Engagement with RMTs in MDD research is of the utmost importance for the validity of predictive analytical methods and long-term use and can be conceptualized as both objective engagement (data availability) and subjective engagement (system usability and experiential factors). Positioning the design of user interfaces within the theoretical framework of the Behavior Change Wheel can help maximize effectiveness. In-app components containing information from credible sources, visual feedback, and access to support provide an opportunity to promote engagement with RMTs while minimizing team resources. Randomized controlled trials are the gold standard in quantifying the effects of in-app components on engagement with RMTs in patients with MDD. Objective: This study aims to evaluate whether a multiparametric RMT system with theoretically informed notifications, visual progress tracking, and access to research team contact details could promote engagement with remote symptom tracking over and above the system as usual. We hypothesized that participants using the adapted app (intervention group) would have higher engagement in symptom monitoring, as measured by objective and subjective engagement. Methods: A 2-arm, parallel-group randomized controlled trial (participant-blinded) with 1:1 randomization was conducted with 100 participants with MDD over 12 weeks. Participants in both arms used the RADAR-base system, comprising a smartphone app for weekly symptom assessments and a wearable Fitbit device for continuous passive tracking. Participants in the intervention arm (n=50, 50%) also had access to additional in-app components. The primary outcome was objective engagement, measured as the percentage of weekly questionnaires completed during follow-up. The secondary outcomes measured subjective engagement (system engagement, system usability, and emotional self-awareness). Results: The levels of completion of the Patient Health Questionnaire-8 (PHQ-8) were similar between the control (67/97, 69%) and intervention (66/97, 68%) arms (P value for the difference between the arms=.83, 95% CI −9.32 to 11.65). The intervention group participants reported slightly higher user engagement (1.93, 95% CI −1.91 to 5.78), emotional self-awareness (1.13, 95% CI −2.93 to 5.19), and system usability (2.29, 95% CI −5.93 to 10.52) scores than the control group participants at follow-up; however, all CIs were wide and included 0. Process evaluation suggested that participants saw the in-app components as helpful in increasing task completion. Conclusions: The adapted system did not increase objective or subjective engagement in remote symptom tracking in our research cohort. This study provides an important foundation for understanding engagement with RMTs for research and the methodologies by which this work can be replicated in both community and clinical settings. Trial Registration: ClinicalTrials.gov NCT04972474; https://clinicaltrials.gov/ct2/show/NCT04972474 International Registered Report Identifier (IRRID): RR2-10.2196/32653